Fundz

Cellens

Cambridge, MA · Other · 9 employees

Cellens is a Tufts University spinout startup that is committed to bringing clarity and confidence to patients and physicians through noninvasive cancer detection. We are developing a pipeline of revolutionary noninvasive and accurate at-home and mail-in cancer monitoring tests.

Funding history

  • Funding Round — $6.4M — Nov 2025
  • Series seed — $585K — Oct 2022

Recent signals

  • Nov 14, 2025: Raised $6.4M
  • Oct 14, 2022: Raised $585K in Series seed

See plans & pricing → Track Cellens’s funding, hiring, and signals — with verified contacts — on Fundz.